3-iodobenzylguanidine has been researched along with Carcinoma, Neuroendocrine in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 7 (70.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Jimenez, C; Núñez, R; Wendt, R | 1 |
Breza, J | 1 |
Bombardieri, E; Chiti, A; Lorenzoni, A; Pepe, G | 1 |
Binse, I; Bockisch, A; Brandau, W; Jentzen, W; Poeppel, TD; Richter, M; Schmitz, J | 1 |
Divgi, C; Ilias, I; Pacak, K | 1 |
Bucerius, J; Mottaghy, FM; Vöö, S | 1 |
Bomanji, JB; Papathanasiou, ND | 1 |
Bennet, A; Caron, P; Grunenwald, S; Maiza, JC; Otal, P; Vezzosi, D | 1 |
Borson-Chazot, F; Giammarile, F | 1 |
Cichocki, A; Cwikla, JB; Durlik, M; Jeziorski, KG; Malkowski, B; Nasierowska-Guttmejer, A; Seklecka, N; Stepień, K; Walecki, J; Zgliczynski, W | 1 |
6 review(s) available for 3-iodobenzylguanidine and Carcinoma, Neuroendocrine
Article | Year |
---|---|
High-specific-activity iodine 131 metaiodobenzylguanidine for the treatment of metastatic pheochromocytoma or paraganglioma: a novel therapy for an orphan disease.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Humans; Intestinal Neoplasms; Iodine Radioisotopes; Neoplasm Metastasis; Neuroblastoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Rare Diseases; Stomach Neoplasms; Therapies, Investigational; Thyroid Neoplasms | 2020 |
Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Contraindications; Humans; Intestinal Neoplasms; Lung Neoplasms; Neuroblastoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Pituitary Neoplasms; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Stomach Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2014 |
Current role of metaiodobenzylguanidine in the diagnosis of pheochromocytoma and medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Animals; Biological Transport; Carcinoma, Neuroendocrine; Humans; Pheochromocytoma; Thyroid Neoplasms | 2011 |
I-131-MIBG therapies.
Topics: 3-Iodobenzylguanidine; Animals; Carcinoma, Neuroendocrine; Clinical Trials as Topic; Humans; Iodine Radioisotopes | 2011 |
¹¹¹In-DTPA⁰-octreotide (Octreoscan), ¹³¹I-MIBG and other agents for radionuclide therapy of NETs.
Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Carcinoma, Neuroendocrine; Humans; Iodine Radioisotopes; Neuroendocrine Tumors; Octreotide; Paraganglioma; Pentetic Acid; Pheochromocytoma; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms | 2012 |
[Neuroendocrine tumours treated with mIBG and radiolabeled peptides].
Topics: 3-Iodobenzylguanidine; Antineoplastic Agents; Carcinoma, Neuroendocrine; Combined Modality Therapy; Humans; Neuroblastoma; Paraganglioma; Peptides; Prognosis; Radiopharmaceuticals | 2006 |
4 other study(ies) available for 3-iodobenzylguanidine and Carcinoma, Neuroendocrine
Article | Year |
---|---|
Multiple endocrine neoplasia 2A (MEN 2A) syndrome.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Carcinoma, Neuroendocrine; Child; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Mutation; Pedigree; Pheochromocytoma; Polymerase Chain Reaction; Positron Emission Tomography Computed Tomography; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed; Young Adult | 2018 |
Discrepant salivary gland response after radioiodine and MIBG therapies.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Aged, 80 and over; Animals; Carcinoma, Neuroendocrine; Child; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiation Dosage; Retrospective Studies; Salivary Glands; Young Adult | 2017 |
Use of 131 I-MIBG therapy in MIBG-positive metastatic medullary thyroid carcinoma.
Topics: 3-Iodobenzylguanidine; Adult; Carcinoma, Neuroendocrine; Female; Humans; Iodine Radioisotopes; Liver Neoplasms; Thyroid Neoplasms; Thyroidectomy; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin - single NET center experience in Poland.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Diagnostic Imaging; Female; Humans; Indium Radioisotopes; Intestinal Neoplasms; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Somatostatin; Stomach Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2007 |